Net Cash Provided by (Used in) Financing Activities of CorMedix Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
CorMedix Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • CorMedix Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $6,092,935.
  • CorMedix Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $238,453,000, a 806% increase from 2024.
  • CorMedix Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $26,319,000, a 53% decline from 2023.
  • CorMedix Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $55,916,804, a 212% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

CorMedix Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $238,453,000 +$212,134,000 +806% 01 Jan 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
2024 $26,319,000 -$29,597,804 -53% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
2023 $55,916,804 +$38,018,563 +212% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
2022 $17,898,241 -$23,859,310 -57% 01 Jan 2022 31 Dec 2022 10-K 12 Mar 2024 2023 FY
2021 $41,757,551 +$1,657,685 +4.1% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $40,099,866 +$14,295,504 +55% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
2019 $25,804,362 -$3,592,708 -12% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $29,397,070 +$8,872,073 +43% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020 2019 FY
2017 $20,524,997 +$13,432,545 +189% 01 Jan 2017 31 Dec 2017 10-K 29 May 2019 2018 FY
2016 $7,092,452 -$36,537,042 -84% 01 Jan 2016 31 Dec 2016 10-K 19 Mar 2018 2017 FY
2015 $43,629,494 +$35,271,578 +422% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2017 2016 FY
2014 $8,357,916 +$3,153,834 +61% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2017 2016 FY
2013 $5,204,082 +$4,077,685 +362% 01 Jan 2013 31 Dec 2013 10-K 12 Mar 2015 2014 FY
2012 $1,126,397 +$1,126,397 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014 2013 FY
2011 $0 -$10,457,270 -100% 01 Jan 2011 31 Dec 2011 10-K 27 Mar 2013 2012 FY
2010 $10,457,270 01 Jan 2010 31 Dec 2010 10-K/A 26 Apr 2012 2011 FY

CorMedix Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $6,092,935 +$6,190,053 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $97,118 -$7,297,524 -101% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $7,200,406 +$4,196,190 +140% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $3,004,216 -$38,576,343 -93% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $41,580,559 +$38,745,895 +1367% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $2,834,664 -$13,132,911 -82% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q1 2019 $15,967,575 +$12,698,412 +388% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $3,269,163 +$2,915,002 +823% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q1 2017 $354,161 +$88,185 +33% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q1 2016 $265,976 -$6,561,692 -96% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $6,827,668 -$1,425,748 -17% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q1 2014 $8,253,416 +$7,778,416 +1638% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q1 2013 $475,000 +$475,000 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q1 2012 $0 01 Jan 2012 31 Mar 2012 10-Q/A 04 Mar 2014 2013 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.